Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP)

The Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments funding opportunity is administered by the Centers for Disease Control and Prevention under the U.S. Department of Health and Human Services. This program reflects the federal government’s ongoing commitment to addressing viral hepatitis as a major public health concern in the United States. The CDC, particularly through its National Center for HIV, Viral Hepatitis, STD, and TB Prevention, leads national efforts to reduce the burden of infectious diseases through surveillance, prevention strategies, and coordinated public health responses. This opportunity is designed to support state, territorial, and local health departments in strengthening their capacity to manage and reduce viral hepatitis transmission. The purpose of this funding is to support comprehensive and integrated viral hepatitis programs that combine surveillance, outbreak response, prevention, testing, and treatment initiatives. The program emphasizes the importance of coordinated public health infrastructure to address hepatitis A, hepatitis B, and hepatitis C across acute, chronic, and perinatal cases. The funding aims to improve data systems, enhance case identification and investigation, and support the use of data to inform targeted interventions. It also promotes the expansion of prevention and care services in high impact and healthcare settings. The scope of the program includes both required and optional components. Required components focus on outbreak response and surveillance as well as planning, partnerships, and promotion activities. These include maintaining disease registries, conducting data matching, generating actionable reports, and strengthening collaboration across agencies and partners. Optional components allow applicants to expand into testing, treatment, and prevention services, as well as the development of perinatal hepatitis C programs. Funds may be used to build infrastructure, enhance data systems, and support service delivery integration, but must align with CDC priorities and program objectives. Eligibility is limited to public health entities, specifically state health departments, local health agencies, and their bona fide agents, including those in U.S. territories and the District of Columbia. In jurisdictions without a city level public health department, county agencies may apply on behalf of the city. Applicants must demonstrate formal arrangements if applying as an agent of an eligible entity. This ensures that funded programs are administered by organizations with the authority and capacity to implement large scale public health interventions. The application process will be conducted electronically, with submissions required through designated federal systems by the stated deadline. Applicants are expected to develop proposals that align with the required program components and demonstrate capacity to implement surveillance and prevention strategies. While specific evaluation criteria are not detailed in the forecast, applications are typically assessed based on alignment with program goals, organizational capacity, and the potential for measurable public health impact. Contact for the opportunity is provided through a CDC program officer, with both email and phone support available for applicant inquiries. The timeline indicates that the opportunity is currently in a forecast stage, with an estimated posting date in October 2026 and an application deadline in December 2026. Awards are expected to be announced in April 2027, with project activities beginning in May 2027. The program represents a significant federal investment, with total funding projected at four hundred fifty million dollars and approximately sixty awards anticipated. This large scale, multi year initiative underscores the importance of sustained and coordinated efforts to eliminate viral hepatitis as a public health threat in the United States.

Align proposal with surveillance capacity building, data driven decision making, and partnership development priorities